Gerges Bustros

American University of Beirut Medical Center

Papers

Total Citations

H-Index

About

Gerges Bustros is a clinical researcher whose work centers on urologic oncology, with a particular focus on improving prognostic tools for prostate carcinoma. His most cited study, published in 2020, developed a novel nomogram that integrates the platelet-to-lymphocyte ratio—a readily available inflammatory marker—to enhance the prediction of lymph node involvement in prostate cancer patients. This contribution addresses a critical gap in preoperative risk stratification, offering clinicians a non-invasive, cost-effective method to guide treatment decisions and potentially reduce unnecessary lymph node dissections. While his citation count reflects a growing interest in this area, Bustros’ work exemplifies the shift toward incorporating systemic inflammatory biomarkers into traditional predictive models, a trend gaining traction in precision oncology. His research underscores the value of combining clinical variables with hematological indices to refine staging accuracy. As the field increasingly recognizes the prognostic significance of host immune responses, Bustros’ nomogram stands as a practical tool that bridges laboratory findings with bedside decision-making, marking him as a contributor to the evolving landscape of prostate cancer management.